Shareholders that Lost Money on GSK plc (GSK) Should Contact Levi & Korsinsky about Pending Class Action - GSK
Portfolio Pulse from
Law firm Levi & Korsinsky has filed a class action securities lawsuit against GSK plc, alleging the company misled investors about Zantac's safety and potential cancer risks between February 2020 and August 2022. The lawsuit claims GSK knew about NDMA sources for decades but did not disclose this information to shareholders.
March 20, 2025 | 11:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
The class action lawsuit could result in significant financial penalties and potential stock price volatility for GSK, stemming from allegations of misleading investors about Zantac's safety and NDMA risks.
The lawsuit alleges systematic misrepresentation about Zantac's safety, which could lead to substantial legal costs, potential settlements, and investor trust erosion.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100